Determination of Captopril in Biological Samples by High-performance Liquid Chromatography with ThioGloTM3 Derivatization
Captopril, a well-known angiotensin converting enzyme (ACE) inhibitor, is widely used for treatment of arterial hypertension. Recent studies suggest that it may also act as a scavenger of free radicals because of its thiol group. Therefore, the present study describes a rapid, sensitive and relatively simple method for the detection of captopril in biological tissues with reverse-phase HPLC. Captopril was first derivatized with ThioGloTM3 [3H-Naphto[2,1-b]pyran,9-acetoxy-2-(4-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)phenyl-3-oxo-)]. It was then detected by fluorescence-HPLC using an Astec C18 column as the stationary phase and a water:acetonitrile:acetic acid:phosphoric acid mixture (50:50; 1 mL/L acids) as the mobile phase (excitation wavelength, 365 nm; emission wavelength, 445 nm). The calibration curve for captopril was linear over a range of 10-2500 nM and the coefficient of variation acquired for the within- and between-run precision for captopril was 0.5 and 3.8%, respectively. The detection limit of captopril with this method was found to be 200 fmol/20 µL injection volume. Its relative recovery from biological samples was determined to the range from 93.3 to 105.3%. Based on these results, we believe that our method is advantageous for captopril determination.
R. Neal et al., "Determination of Captopril in Biological Samples by High-performance Liquid Chromatography with ThioGloTM3 Derivatization," Biomedical Chromatography, John Wiley & Sons, Jan 2001.
The definitive version is available at https://doi.org/10.1002/bmc.95
International Standard Serial Number (ISSN)
Article - Journal
© 2001 John Wiley & Sons, All rights reserved.
01 Jan 2001